Mustang Bio Inc.

NASDAQ: MBIO · Real-Time Price · USD
1.74
-0.04 (-2.25%)
At close: Aug 15, 2025, 3:59 PM
1.69
-2.88%
After-hours: Aug 15, 2025, 07:52 PM EDT

Mustang Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
12.66M 14.23M 6.84M 3.52M 4.27M 1.34M 6.23M 9.56M 15.38M 58.1M 75.66M 91.36M 107.37M 122.22M 109.62M 120.88M 129.92M 129.37M
Short-Term Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a 375K 375K 375K 750K 750K 750K 750K 1M n/a 1M 1M 1M 1M 1M 1M
Other Long-Term Assets
n/a n/a 250K 250K 250K 530K 833K 1.08M 253K 257K 261K 1.32M 359K 286K 362K 254K 255K 255K
Receivables
217K 467K 402K 237K 728K 6.74M 3.88M n/a n/a n/a 299K 33K 33K 32K 50K 41K 32K 17K
Inventory
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Current Assets
172K 211K 1.36M 2.29M 2.32M 1.17M 1.23M 4.03M 7.19M 3.03M 3.2M n/a n/a n/a n/a n/a n/a n/a
Total Current Assets
13.05M 14.91M 8.61M 6.05M 7.32M 9.24M 11.35M 13.59M 22.58M 61.13M 78.85M 94.45M 109.38M 124.15M 111.71M 121.95M 131.34M 130.97M
Property-Plant & Equipment
n/a n/a 452K 513K 575K 4.45M 4.81M 5.15M 5.51M 11.47M 12.31M 13.07M 11.17M 11.52M 12.1M 11.5M 10.61M 9.6M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Assets
n/a n/a 702K 1.14M 1.2M 5.35M 6.4M 6.98M 6.51M 12.48M 13.57M 14.39M 12.53M 12.81M 13.46M 12.76M 11.87M 10.85M
Total Assets
13.05M 14.91M 9.31M 7.19M 8.52M 14.59M 17.74M 20.57M 29.09M 73.61M 92.42M 108.84M 121.91M 136.96M 125.17M 134.71M 143.21M 141.82M
Account Payables
5.65M 6.31M 7.46M 8.76M 8.93M 11.28M 6.32M 5.5M 6.71M 6.4M 6.83M 7M 5.44M 5.54M 3.51M 4.63M 2.94M 2.92M
Deferred Revenue
150K n/a 150K 270K 270K 270K 270K n/a 270K 270K 270K n/a 270K 270K 270K 270K n/a -3.04M
Short-Term Debt
n/a n/a 456K 442K 429K 570K 520K 453K 409K 629K n/a 595K 368K 358K n/a 329K 346K 284K
Other Current Liabilities
4.2M 160K -513K 2.81M 2.38M 361K 2.05M 2.19M 2.37M 2.51M 1.41M 2.65M 2.35M 1.74M 1.28M 2.87M 1.11M 1.91M
Total Current Liabilities
10M 11.15M 12.61M 15.04M 15.92M 17.44M 15.37M 14.17M 12.86M 12.67M 15.11M 13.56M 10.98M 10.78M 10.81M 10.46M 6.36M 6.59M
Long-Term Debt
n/a n/a n/a n/a n/a n/a n/a n/a n/a 27.58M 27.44M 27.29M 27.15M 26.99M n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Total Long-Term Liabilities
150K 150K 572K 811K 926K 2.1M 2.25M 2.39M 2.51M 31.12M 31.04M 30.95M 28.92M 28.85M 1.96M 2.03M 1.82M 1.88M
Total Liabilities
10.15M 11.3M 13.18M 15.85M 16.85M 19.54M 17.62M 16.56M 15.37M 43.79M 46.15M 44.51M 39.9M 39.63M 12.77M 12.49M 8.18M 8.46M
Total Debt
n/a n/a 878K 983K 1.08M 2.4M 2.5M 2.58M 2.65M 31.48M 31.38M 31.28M 29.01M 28.93M 2.03M 2.09M 2.17M 2.16M
Common Stock
n/a n/a 5K 3K 3K 1K 1K 1K 1K 1K 11K 11K 10K 10K 9K 9K 9K 8K
Retained Earnings
-397.64M -396.88M -396.72M -395.77M -394.36M -386.16M -380.97M -372.36M -362.3M -346.06M -329.37M -309.74M -290.74M -271.64M -251.84M -231.79M -214.79M -200.43M
Comprehensive Income
n/a n/a 611K n/a n/a n/a 591K 4K n/a n/a 1.11M n/a 28K 27K 4.33M 37K 185K 218K
Shareholders Equity
2.89M 3.61M -3.87M -8.66M -8.33M -4.94M 123K 4.01M 13.71M 29.82M 46.27M 64.33M 82.01M 97.33M 112.4M 122.21M 135.03M 133.36M
Total Investments
n/a n/a n/a 375K 375K 375K 750K 750K 750K 750K 1M n/a 1M 1M 1M 1M 1M 1M